Skip to main content
Erschienen in: Archives of Osteoporosis 1/2023

01.12.2023 | Original Article

Osteoporosis treatment gap in patients at risk of fracture in Egypt: a multi-center, cross-sectional observational study

verfasst von: Yasser El Miedany, Maha El Gaafary, Naglaa Gadallah, Safaa Mahran, Nihal Fathi, Mohamed Hassan Abu Zaid, Samar Abdel Hamid Tabra, Waleed Hassan, Walaa Elwakil

Erschienen in: Archives of Osteoporosis | Ausgabe 1/2023

Einloggen, um Zugang zu erhalten

Abstract

Summary

Despite the wide availability of a wide variety of approved osteoporosis medications and DXA scan centers in Egypt, only a minority of patients at high risk of sustaining a fragility fracture receive treatment, even after their first fracture. Such big “treatment gap” leaves the most high-risk individuals unprotected against fragility fractures. This study provides a benchmark to monitor national trends in osteoporosis management and service uptake.

Purpose

To assess the treatment gap among men and postmenopausal women presenting with a fragility fracture, and to analyze the characteristics and fracture risks of the patients presenting with an index fragility fracture.

Methods

This was a multi-center, cross-sectional, observational study. Both men and postmenopausal women, admitted with an osteoporotic fracture (whether major osteoporosis or hip fracture), were consecutively recruited for this work. The fracture risk was assessed based on their FRAX calculation prior to the index fracture. All the patients were assessed for their falls and sarcopenia risks. Blood tests for bone profile as well as DXA scan were offered to all the patients.

Results

Two hundred and thirty-six patients presenting with fragility fractures were included in this work. 70.8% were women and 29.2% were men. Mean age was 70.1 (SD = 9.2) years. Ten-year probability of fracture (without BMD) was high in 65.9% of the postmenopausal women and 40.3% of the men. 82.1% of the postmenopausal women and 100% in men identified to be eligible for osteoporosis therapy did not receive any form of osteoporosis therapy. FRAX score correlated significantly with bone mineral density assessment at both hip and spine. Falls, sarcopenia, and functional disability showed significant relation to the fracture risk.

Conclusions

There is a large treatment gap in Egyptian older adults. The recent guidelines for osteoporosis management in Egypt endorsed fracture centric approach to identify people at risk. The gap appears to be related to a low rate of osteoporosis diagnosis and lack of patient education.
Literatur
1.
Zurück zum Zitat Eastell R, Rosen CJ, Black DM, Cheung AM, Murad MH, Shoback D (2019) Pharmacological management of osteoporosis in postmenopausal women: an Endocrine Society* clinical practice guideline. J Clin Endocrinol Metab 104(5):1595–1622CrossRefPubMed Eastell R, Rosen CJ, Black DM, Cheung AM, Murad MH, Shoback D (2019) Pharmacological management of osteoporosis in postmenopausal women: an Endocrine Society* clinical practice guideline. J Clin Endocrinol Metab 104(5):1595–1622CrossRefPubMed
2.
Zurück zum Zitat Johansson H, Siggeirsdottir K, Harvey NC, Oden A, Gudnason V, McCloskey E et al (2017) Imminent risk of fracture after fracture. Osteoporos Int 28(3):775–780CrossRefPubMed Johansson H, Siggeirsdottir K, Harvey NC, Oden A, Gudnason V, McCloskey E et al (2017) Imminent risk of fracture after fracture. Osteoporos Int 28(3):775–780CrossRefPubMed
3.
Zurück zum Zitat Kanis JA, Svedbom A, Harvey N et al (2014) The osteoporosis treatment gap. J Bone Miner Res 29:1926–1928CrossRefPubMed Kanis JA, Svedbom A, Harvey N et al (2014) The osteoporosis treatment gap. J Bone Miner Res 29:1926–1928CrossRefPubMed
4.
Zurück zum Zitat McCloskey E, Rathi J, Heijmans S, Blagden M, Cortet B, Czerwinski E, Hadji P, Payer J, Palmer K, Stad R, O'Kelly J, Papapoulos S (2021) The osteoporosis treatment gap in patients at risk of fracture in European primary care: a multi-country cross-sectional observational study. Osteoporos Int 32(2):251–259CrossRefPubMed McCloskey E, Rathi J, Heijmans S, Blagden M, Cortet B, Czerwinski E, Hadji P, Payer J, Palmer K, Stad R, O'Kelly J, Papapoulos S (2021) The osteoporosis treatment gap in patients at risk of fracture in European primary care: a multi-country cross-sectional observational study. Osteoporos Int 32(2):251–259CrossRefPubMed
6.
Zurück zum Zitat Kanis JA, Johnell O, Oden A et al (2008) FRAX and the assessment of fracture probability in men and women from the UK. Osteoporos Int 19(4):385–397CrossRefPubMedPubMedCentral Kanis JA, Johnell O, Oden A et al (2008) FRAX and the assessment of fracture probability in men and women from the UK. Osteoporos Int 19(4):385–397CrossRefPubMedPubMedCentral
7.
Zurück zum Zitat El-Tawab SS, Saba EKA, Elweshahi HMT, Ashry MH (2016) Knowledge of osteoporosis among women in Alexandria (Egypt): a community based survey. Egypt Rheumatol 38(3):225–231CrossRef El-Tawab SS, Saba EKA, Elweshahi HMT, Ashry MH (2016) Knowledge of osteoporosis among women in Alexandria (Egypt): a community based survey. Egypt Rheumatol 38(3):225–231CrossRef
8.
Zurück zum Zitat El Miedany Y, Abu-Zaid MH, El Gaafary M et al (2021) Egyptian consensus on treat-to-target approach for osteoporosis: a clinical practice guideline from the Egyptian Academy of bone health and metabolic bone diseases. Egypt Rheumatol Rehabil 48:5CrossRef El Miedany Y, Abu-Zaid MH, El Gaafary M et al (2021) Egyptian consensus on treat-to-target approach for osteoporosis: a clinical practice guideline from the Egyptian Academy of bone health and metabolic bone diseases. Egypt Rheumatol Rehabil 48:5CrossRef
9.
Zurück zum Zitat NIH Consensus Development Panel on Osteoporosis Prevention (2001) Diagnosis, and Therapy. Osteoporosis prevention, diagnosis, and therapy. JAMA 285(6):785–795CrossRef NIH Consensus Development Panel on Osteoporosis Prevention (2001) Diagnosis, and Therapy. Osteoporosis prevention, diagnosis, and therapy. JAMA 285(6):785–795CrossRef
10.
Zurück zum Zitat El Miedany Y, El Gaafary M, Toth M, Palmer D, Ahmed I (2011) Falls risk assessment score (FRAS): time to rethink. J Clin Gerontol Geriatr 2(1):21–26CrossRef El Miedany Y, El Gaafary M, Toth M, Palmer D, Ahmed I (2011) Falls risk assessment score (FRAS): time to rethink. J Clin Gerontol Geriatr 2(1):21–26CrossRef
11.
Zurück zum Zitat Malmstrom TK, Miller DK, Simonsick EM, Ferrucci L, Morley JE (2016) SARC-F: a symptom score to predict persons with sarcopenia at risk for poor functional outcomes. J Cachexia Sarcopenia Muscle 7(1):28–36CrossRefPubMed Malmstrom TK, Miller DK, Simonsick EM, Ferrucci L, Morley JE (2016) SARC-F: a symptom score to predict persons with sarcopenia at risk for poor functional outcomes. J Cachexia Sarcopenia Muscle 7(1):28–36CrossRefPubMed
12.
Zurück zum Zitat El Miedany Y, El Gaafary M, Youssef SS, Palmer D (2010) Incorporating patient reported outcome measures in clinical practice: development and validation of a questionnaire for inflammatory arthritis. Clin Exp Rheumatol 28(5):734–744PubMed El Miedany Y, El Gaafary M, Youssef SS, Palmer D (2010) Incorporating patient reported outcome measures in clinical practice: development and validation of a questionnaire for inflammatory arthritis. Clin Exp Rheumatol 28(5):734–744PubMed
13.
Zurück zum Zitat Gadallah N, El Miedany Y (2022) Operative secondary prevention of fragility fractures: national clinical standards for fracture liaison service in Egypt—an initiative by the Egyptian Academy of Bone Health. Egypt Rheumatol Rehabil 49:11CrossRef Gadallah N, El Miedany Y (2022) Operative secondary prevention of fragility fractures: national clinical standards for fracture liaison service in Egypt—an initiative by the Egyptian Academy of Bone Health. Egypt Rheumatol Rehabil 49:11CrossRef
14.
Zurück zum Zitat Schnell AD, Curtis JR, Saag KG (2018 Dec) Importance of recent fracture as predictor of imminent fracture risk. Curr Osteoporos Rep 16(6):738–745CrossRefPubMed Schnell AD, Curtis JR, Saag KG (2018 Dec) Importance of recent fracture as predictor of imminent fracture risk. Curr Osteoporos Rep 16(6):738–745CrossRefPubMed
16.
Zurück zum Zitat Hadji P, Schweikert B, Kloppmann E, Gille P, Joeres L, Toth E, Möckel L, Glüer CC (2021 Sep) Osteoporotic fractures and subsequent fractures: imminent fracture risk from an analysis of German real-world claims data. Arch Gynecol Obstet 304(3):703–712CrossRefPubMedPubMedCentral Hadji P, Schweikert B, Kloppmann E, Gille P, Joeres L, Toth E, Möckel L, Glüer CC (2021 Sep) Osteoporotic fractures and subsequent fractures: imminent fracture risk from an analysis of German real-world claims data. Arch Gynecol Obstet 304(3):703–712CrossRefPubMedPubMedCentral
17.
Zurück zum Zitat El Miedany Y, Gadallah NA, Toth M (2022) Optimizing osteoporosis management: targeting to treat — an initiative by the Egyptian Academy of Bone Health. Egypt Rheumatol Rehabil 49:61CrossRef El Miedany Y, Gadallah NA, Toth M (2022) Optimizing osteoporosis management: targeting to treat — an initiative by the Egyptian Academy of Bone Health. Egypt Rheumatol Rehabil 49:61CrossRef
18.
Zurück zum Zitat Ström O, Borgström F, Kanis JA et al (2011) Osteoporosis: burden, health care provision and opportunities in the EU. A report prepared in collaboration with the International Osteoporosis Foundation (IOF) and the European Federation of Pharmaceutical Industry Associations (EFPIA). Arch Osteoporos 6:59–155CrossRefPubMed Ström O, Borgström F, Kanis JA et al (2011) Osteoporosis: burden, health care provision and opportunities in the EU. A report prepared in collaboration with the International Osteoporosis Foundation (IOF) and the European Federation of Pharmaceutical Industry Associations (EFPIA). Arch Osteoporos 6:59–155CrossRefPubMed
19.
Zurück zum Zitat Kanis JA, Cooper C, Rizzoli R et al (2017) Identification and management of patients at increased risk of osteoporotic fracture: outcomes of an ESCEO expert consensus meeting. Osteoporos Int 28:2023–2034CrossRefPubMedPubMedCentral Kanis JA, Cooper C, Rizzoli R et al (2017) Identification and management of patients at increased risk of osteoporotic fracture: outcomes of an ESCEO expert consensus meeting. Osteoporos Int 28:2023–2034CrossRefPubMedPubMedCentral
20.
Zurück zum Zitat Abouzid MR, Ali K, Elkhawas I, Elshafei SM (2022) An overview of diabetes mellitus in Egypt and the significance of integrating preventive cardiology in diabetes management. Cureus 14(7):e27066PubMedPubMedCentral Abouzid MR, Ali K, Elkhawas I, Elshafei SM (2022) An overview of diabetes mellitus in Egypt and the significance of integrating preventive cardiology in diabetes management. Cureus 14(7):e27066PubMedPubMedCentral
Metadaten
Titel
Osteoporosis treatment gap in patients at risk of fracture in Egypt: a multi-center, cross-sectional observational study
verfasst von
Yasser El Miedany
Maha El Gaafary
Naglaa Gadallah
Safaa Mahran
Nihal Fathi
Mohamed Hassan Abu Zaid
Samar Abdel Hamid Tabra
Waleed Hassan
Walaa Elwakil
Publikationsdatum
01.12.2023
Verlag
Springer London
Erschienen in
Archives of Osteoporosis / Ausgabe 1/2023
Print ISSN: 1862-3522
Elektronische ISSN: 1862-3514
DOI
https://doi.org/10.1007/s11657-023-01252-8

Weitere Artikel der Ausgabe 1/2023

Archives of Osteoporosis 1/2023 Zur Ausgabe

Arthropedia

Grundlagenwissen der Arthroskopie und Gelenkchirurgie. Erweitert durch Fallbeispiele, Videos und Abbildungen. 
» Jetzt entdecken

Update Orthopädie und Unfallchirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.